Modular microfluidic platform for solubility measurement, nucleation statistics and polymorph screening of active pharmaceutical ingredients: Irbesartan, Rimonabant, Aripiprazole and Sulfathiazole

This publication has 40 references indexed in Scilit:

• Rimonabant Dimorphism and Its Pressure–Temperature Phase Diagram: A Delicate Case of Overall Monotropic Behavior
  Journal of Pharmaceutical Sciences, 2013
• Nucleation and polymorphism explored via an easy-to-use microfluidic tool
  Journal of Crystal Growth, 2012
• Quantitative analysis of sulfathiazole polymorphs in ternary mixtures by attenuated total reflectance infrared, near-infrared and Raman spectroscopy
  Journal of Pharmaceutical and Biomedical Analysis, 2010
• A Rapid Method for Screening Crystallization Conditions and Phases of an Active Pharmaceutical Ingredient
  Organic Process Research & Development, 2009
• Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications
  Journal of Pharmaceutical Sciences, 2009
• Reaching One Single and Stable Critical Cluster through Finite-Sized Systems
  Crystal Growth & Design, 2009
• Using Temperature To Crystallize Proteins: A Mini-Review
  Crystal Growth & Design, 2008
• Solubility of Irbesartan (Form A) in Different Solvents between 278 K and 323 K
  Journal of Chemical & Engineering Data, 2007
• Direct Determination of the Nucleation Rates of Protein Crystals
  The Journal of Physical Chemistry B, 1999
• NMR study of desmotropy in Irbesartan, a tetrazole-containing pharmaceutical compound
  Journal of the Chemical Society, Perkin Transactions 2, 1998